Hadjigeorgiou Nikoleta, Melanarkiti Despo, Plakomyti Theodora Eleni, Demou Vasileios, Giannakopoulos Vasileios, Sapouridis Chariton, Mouzarou Angeliki
Department of Cardiology, General Hospital Paphos, State Health Services Organization, 8026 Paphos, Cyprus.
Rev Cardiovasc Med. 2025 Jun 30;26(6):36771. doi: 10.31083/RCM36771. eCollection 2025 Jun.
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure to treat severe aortic stenosis in select patients. Patients who have undergone TAVI are at high risk of infective endocarditis (IE), especially during the first year post-operation. Early diagnosis of IE is essential to initiate targeted antibiotic therapy and/or surgical intervention. However, the early detection of IE following TAVI poses significant diagnostic challenges. Current imaging techniques, including echocardiography, nuclear imaging, and magnetic resonance imaging, have varying degrees of sensitivity and specificity, each with inherent limitations. Nuclear imaging modalities, such as positron emission tomography/computed tomography using F-fluorodeoxyglucose (F-FDG PET/CT) and white blood cell single photon emission computed tomography/computed tomography (WBC SPECT/CT), have shown promise in early IE detection, particularly due to the ability of these methods to identify metabolic and anatomical abnormalities. However, false-positive results related to post-operative inflammation complicate data interpretation, and limited data exist for using these methods in very early IE detection post-TAVI. Intracardiac echocardiography (ICE) offers enhanced visualization of prosthetic valve leaflets, but the invasive nature of ICE restricts its widespread use. Whole-body imaging, such as F-FDG PET/CT, facilitates the identification of distant lesions and systemic complications, aiding diagnosis and treatment decisions. Diagnosing IE after TAVI is especially challenging within the first 60 days post-procedure, a critical period when imaging findings may be inconclusive due to false negatives or limited availability of advanced modalities. This review underscores the diagnostic complexity of very early and early (0-60 days) IE post-TAVI, emphasizing the need for a multimodal imaging approach to overcome the limitations of individual modalities. Nonetheless, early antimicrobial therapy should be considered even without definitive imaging findings, highlighting the importance of clinical vigilance in managing this challenging condition.
经导管主动脉瓣植入术(TAVI)是一种用于治疗特定患者严重主动脉瓣狭窄的微创手术。接受过TAVI的患者发生感染性心内膜炎(IE)的风险很高,尤其是在术后第一年。IE的早期诊断对于启动针对性的抗生素治疗和/或手术干预至关重要。然而,TAVI后IE的早期检测面临重大诊断挑战。目前的成像技术,包括超声心动图、核成像和磁共振成像,具有不同程度的敏感性和特异性,每种技术都有其固有的局限性。核成像方式,如使用F-氟脱氧葡萄糖(F-FDG)的正电子发射断层扫描/计算机断层扫描(PET/CT)和白细胞单光子发射计算机断层扫描/计算机断层扫描(WBC SPECT/CT),在IE早期检测中显示出前景,特别是因为这些方法能够识别代谢和解剖异常。然而,与术后炎症相关的假阳性结果使数据解释复杂化,并且在TAVI后极早期IE检测中使用这些方法的数据有限。心腔内超声心动图(ICE)可增强人工瓣膜小叶的可视化,但ICE的侵入性限制了其广泛应用。全身成像,如F-FDG PET/CT,有助于识别远处病变和全身并发症,辅助诊断和治疗决策。在术后60天内诊断TAVI后的IE尤其具有挑战性,这是一个关键时期,由于假阴性或先进检查手段有限,成像结果可能不明确。本综述强调了TAVI后极早期和早期(0-60天)IE的诊断复杂性,强调需要采用多模态成像方法来克服个体检查手段的局限性。尽管如此,即使没有明确的成像结果,也应考虑早期抗菌治疗,突出了临床警惕性在管理这种具有挑战性疾病中的重要性。